SteadyMed receives notice of allowance for European patent
SteadyMed announced it received a Notice of Allowance from the EPO for Patent Application (13720085.3) related to enhanced infusion-site pain reduction for drug delivery devices. SteadyMed intends to commercialize Trevyent in the U.S. and has signed license and supply agreement with Cardiome. October 12, 2017